The impacted products have now been given a Class I risk classification by the U.S. Food and Drug Administration.
Trump's staff is laying the groundwork to prepare for a new FDA commissioner and make their mark at the agency.
In October, the FDA in collaboration with the U.S. Customs and Border Protection (CBP), seized about three million units of ...
Olympus advised providers to stop using an endoscope accessory due to an infection risk linked to 120 injuries and one death.
A discussion of the development of consumer protection law in the US through the enactment of key legislation and formation ...
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...
With Donald Trump taking office and Robert F. Kennedy Jr. poised to assume the nation’s top health role, it seems the agency ...
After plugging billions into its manufacturing network to meet rampant demand for Mounjaro and Zepbound, Eli Lilly is looking ...
On December 20, 2024, the FDA granted accelerated approval to the combination of encorafenib (Braftovi), cetuximab (Erbitux), and mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin) in metastatic ...
FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.
After thousands of complaints about complications, the FDA has issued an open letter to veterinarians to be alert to serious ...